12 Month Price Forecast For A
Distance to A Price Forecasts
A Price Momentum
🤔 Considering Agilent (A)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: January 23, 2025 2:00 AM UTC
A Analyst Ratings & Price Targets
Based on our analysis of 24 Wall Street analysts, A has a consensus that is neutral. The median price target is $150.00, with forecasts ranging from $135.00 to $165.00. Currently, there are 8 Buy ratings, 10 Hold ratings, and 1 Sell ratings.
With A currently trading at $152.60, the median price forecast suggests a -1.7% downside. The most optimistic forecast comes from Patrick Donnelly at Citigroup, projecting a 8.1% upside, while Luke Sergott at Barclays provides the most conservative target, suggesting a -11.5% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
A Analyst Consensus
A Price Target Range
Latest A Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for A.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Dec 13, 2024 | B of A Securities | Derik De Bruin | Neutral | Maintains | $150.00 |
| Dec 9, 2024 | Wells Fargo | Brandon Couillard | Overweight | Maintains | $155.00 |
| Nov 27, 2024 | Barclays | Luke Sergott | Underweight | Maintains | $135.00 |
| Nov 26, 2024 | Bernstein | Eve Burstein | Market Perform | Maintains | $135.00 |
| Nov 26, 2024 | JP Morgan | Rachel Vatnsdal | Overweight | Maintains | $160.00 |
| Oct 15, 2024 | Barclays | Luke Sergott | Underweight | Maintains | $145.00 |
| Oct 1, 2024 | Evercore ISI Group | Vijay Kumar | In-Line | Maintains | $145.00 |
| Aug 27, 2024 | Wells Fargo | Brandon Couillard | Overweight | Initiates | $157.00 |
| Aug 23, 2024 | Barclays | Luke Sergott | Underweight | Maintains | $135.00 |
| Aug 22, 2024 | TD Cowen | Dan Brennan | Buy | Maintains | $160.00 |
| Aug 22, 2024 | UBS | Elizabeth Garcia | Neutral | Maintains | $150.00 |
| Aug 22, 2024 | B of A Securities | Derik De Bruin | Neutral | Maintains | $147.00 |
| Aug 22, 2024 | Evercore ISI Group | Vijay Kumar | In-Line | Maintains | $135.00 |
| Aug 22, 2024 | Citigroup | Patrick Donnelly | Buy | Maintains | $165.00 |
| Jul 10, 2024 | Citigroup | Patrick Donnelly | Buy | Upgrade | $150.00 |
| Jul 2, 2024 | Evercore ISI Group | Ross Muken | In-Line | Maintains | $130.00 |
| Jun 27, 2024 | Wolfe Research | Doug Schenkel | Peer Perform | Downgrade | $0.00 |
| Jun 25, 2024 | B of A Securities | Derik De Bruin | Neutral | Maintains | $140.00 |
| Jun 3, 2024 | Jefferies | Brandon Couillard | Hold | Downgrade | $135.00 |
| May 31, 2024 | Barclays | Luke Sergott | Underweight | Maintains | $125.00 |
Stocks Similar to Agilent Technologies, Inc.
The following stocks are similar to Agilent based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Agilent Technologies, Inc. (A) Financial Data
Agilent Technologies, Inc. has a market capitalization of $43.57B with a P/E ratio of 34.5x. The company generates $6.51B in trailing twelve-month revenue with a 54.3% profit margin.
Revenue growth is +7.8% quarter-over-quarter, while maintaining an operating margin of +24.8% and return on equity of +21.9%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
Agilent Technologies, Inc. (A) Company Overview
About Agilent Technologies, Inc.
Provides solutions for life sciences and diagnostics.
Agilent Technologies operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The company generates revenue by selling a wide range of analytical instruments, consumables, and software, along with offering various services such as maintenance, training, and consulting to support its products.
Headquartered in Santa Clara, California, Agilent Technologies was incorporated in 1999. The company serves global markets through a diverse sales approach including direct sales, distributors, and e-commerce, catering to the growing needs of the life sciences and diagnostics sectors.
Company Information
Sector
Healthcare
Industry
Diagnostics & Research
Employees
17,400
CEO
Mr. Padraig McDonnell
Country
United States
IPO Year
1999
Website
www.agilent.comAgilent Technologies, Inc. (A) Latest News & Analysis
Agilent Technologies, Inc. (A) J.P. Morgan 43rd Annual Healthcare Conference (Transcript)
7 days agoAgilent Technologies will participate in the J.P. Morgan 43rd Annual Healthcare Conference on January 14, 2025, at 12:45 PM ET, with CEO Padraig McDonnell and CFO Robert McMahon.
Agilent's participation in a major healthcare conference highlights its strategic positioning and potential investor interest, which could influence stock performance and market sentiment.
A is experiencing challenges due to slowing demand in end markets and regulatory issues in China, which may impact its growth prospects.
Slowing demand and regulatory issues in China could hinder A's revenue growth, impacting profitability and investor confidence, potentially leading to stock price volatility.
Agilent Technologies awarded the Solutions Innovation Research Awards to three professors for their contributions to battery research, crucial for improving efficiency and durability in energy solutions.
Agilent's recognition of battery research advancements highlights its commitment to innovation in sustainable technology, potentially enhancing its market position and attracting investor interest.
Agilent (A) reported earnings 30 days ago; investors should monitor upcoming developments and market responses for insights into the stock's future performance.
Agilent's recent earnings report can indicate future performance trends, affecting stock price and investor sentiment, crucial for decision-making.
Investors should monitor Agilent (A) stock due to notable activity in the options market recently.
Increased activity in Agilent's options market may signal significant price movement or volatility ahead, impacting stock performance and investor sentiment.
Agilent Technologies Inc. (NYSE: A) will present at the J.P. Morgan Healthcare Conference on Jan. 14, 2025, at 9:45 a.m. PT. A live webcast will be available on their Investor Relations website.
Agilent Technologies' participation in a major healthcare conference highlights its strategic direction and potential growth, influencing investor sentiment and stock performance.
Frequently Asked Questions About A Stock
What is Agilent Technologies, Inc.'s (A) stock forecast for 2025?
Based on our analysis of 24 Wall Street analysts, Agilent Technologies, Inc. (A) has a median price target of $150.00. The highest price target is $165.00 and the lowest is $135.00.
Is A stock a good investment in 2025?
According to current analyst ratings, A has 8 Buy ratings, 10 Hold ratings, and 1 Sell ratings. The stock is currently trading at $152.60. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for A stock?
Wall Street analysts predict A stock could reach $150.00 in the next 12 months. This represents a -1.7% decrease from the current price of $152.60. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Agilent Technologies, Inc.'s business model?
Agilent Technologies operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The company generates revenue by selling a wide range of analytical instruments, consumables, and software, along with offering various services such as maintenance, training, and consulting to support its products.
What is the highest forecasted price for A Agilent Technologies, Inc.?
The highest price target for A is $165.00 from Patrick Donnelly at Citigroup, which represents a 8.1% increase from the current price of $152.60.
What is the lowest forecasted price for A Agilent Technologies, Inc.?
The lowest price target for A is $135.00 from Luke Sergott at Barclays, which represents a -11.5% decrease from the current price of $152.60.
What is the overall A consensus from analysts for Agilent Technologies, Inc.?
The overall analyst consensus for A is neutral. Out of 24 Wall Street analysts, 8 rate it as Buy, 10 as Hold, and 1 as Sell, with a median price target of $150.00.
How accurate are A stock price projections?
Stock price projections, including those for Agilent Technologies, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
